OCEAN BIOMEDICAL INC (OCEA) Stock Price, Quote, News and Overview
NASDAQ:OCEA - Nasdaq - US67644C1045 - Common Stock - Currency: USD
OCEA Quote, Performance and Key Statistics
OCEAN BIOMEDICAL INC
NASDAQ:OCEA (1/30/2025, 4:45:08 PM)
After market: 0.1969 +0.01 (+3.91%)0.1895
-0.05 (-22.05%)
The current stock price of OCEA is 0.1895 USD. In the past month the price decreased by -68.42%. In the past year, price decreased by -65.94%.
OCEA Latest News, Press Releases and Analysis
On Thursday, there are stocks with unusual volume. Let's take a look.
Volume analysis on 2025-01-30: stocks with an unusual volume in today's session.
Which stocks are most active on Wednesday?
Discover the most active stocks in Wednesday's session. Stay informed about the stocks that are generating the most trading volume!
Let's uncover which stocks are experiencing notable gaps during today's session.
The session on Wednesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Ocean Biomedical Advances Malaria Vaccine Research with New NIH Funding and Expedited Development Pathway
Providence, RI, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Ocean Biomedical (NASDAQ: OCEA) announced today that its Scientific Co-founder, Dr. Jonathan Kurtis,...
OCEA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 16.34 | 310.40B | ||
| AMGN | AMGEN INC | 14.78 | 152.67B | ||
| GILD | GILEAD SCIENCES INC | 21.88 | 120.83B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 859.61 | 112.90B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.04 | 75.06B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.81B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 35.75B | ||
| BNTX | BIONTECH SE-ADR | N/A | 29.13B | ||
| ONC | BEIGENE LTD-ADR | N/A | 24.16B | ||
| NTRA | NATERA INC | N/A | 23.27B | ||
| BIIB | BIOGEN INC | 8.95 | 21.31B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.49B |
Related stock screener links
About OCEA
Company Profile
Ocean Biomedical, Inc. is a biopharmaceutical company. The company is headquartered in New York City, New York. The company went IPO on 2021-09-15. The firm is focused on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The firm helps to accelerates the development and commercialization of assets from research universities and medical centers. In oncology, it is engaged in developing a mono-specific and two bi-specific humanized monoclonal antibodies (mAb), product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer (NSCLC), and of glioblastoma multiforme (GBM). The company offers three product candidates based on the novel target discoveries: a malaria vaccine candidate targeting either or both of PfSEA-1, and parasite antigen PfGARP, which is referred to as its ODA-570 candidate; a humanized mAb malaria therapeutic candidate targeting PfGARP, which is referred to as ODA-611 candidate, and a small molecule malaria therapeutic candidate targeting PfGARP, which is referred to as ODA-579 candidate.
Company Info
OCEAN BIOMEDICAL INC
515 Madison Ave Suite 8078
New York City NEW YORK US
Employees: 9
Company Website: https://www.oceanbiomedical.com/
Investor Relations: https://investors.oceanbiomedical.com/
Phone: 16469082658
OCEA FAQ
What is the stock price of OCEA?
The current stock price of OCEA is 0.1895 USD.
What is the symbol for OCEAN BIOMEDICAL INC stock?
The exchange symbol of OCEAN BIOMEDICAL INC is OCEA and it is listed on the Nasdaq exchange.
On which exchange is OCEA stock listed?
OCEA stock is listed on the Nasdaq exchange.
Is OCEA a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for OCEA, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of OCEA.
Does OCEA stock pay dividends?
OCEA does not pay a dividend.
What is the Price/Earnings (PE) ratio of OCEA?
OCEA does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.3).
What is the Short Interest ratio of OCEA stock?
The outstanding short interest for OCEA is 1.91% of its float.
OCEA Technical Analysis
OCEA Financial Highlights
Over the last trailing twelve months OCEA reported a non-GAAP Earnings per Share(EPS) of -1.3. The EPS decreased by 55.93% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -1900.49% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
OCEA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to OCEA. The Buy consensus is the average rating of analysts ratings from 7 analysts.